Colorectal cancer patients are predominantly middle-aged and elderly individuals (61.22 ± 11.10 vs. 57.64 ± 12 years old), with reduced metabolic function making them more susceptible to insulin resistance and impaired insulin secretion. The gene discussed is INS; the disease is colorectal cancer.